Latest Drug Safety news
FDA Panel Backs Two Peptides For Compounding, Rejects One
posted July 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Advisers Dismiss Safety Warnings, Back Four Peptide Treatments
posted July 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
ENDO: GLP-1 Receptor Agonists Tied to Higher Hypotension Risk in Patients on BP Meds
posted June 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
ASH: No Specific Harms Found for Hydroxyurea Use During Pregnancy
posted December 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes 
Dietary Nitrate From Beetroot Juice Promising for Pregnant Women With CKD 
Wildfires Now Top Source of Unhealthy Air for Pregnant Women in U.S. .jpg)
Once-Weekly Oral Islatravir-Lenacapavir Noninferior to Daily B/F/TAF in HIV Related Articles
Two HLA Class I Alleles Independently Linked to Allopurinol-Induced SCARs 
FDA Sends 100 Cease-and-Desist Letters in Crackdown on DTC Drug Advertisements 
FDA Creates "Green List" of GLP-1 Drug Ingredients Approved for Entry in the U.S. 
Benefits of Long-Term Routine Lab Drug Toxicity Monitoring Unclear in RA Monthly Specialist Briefings
Stay Connected
